Hiroto Iinuma Selected Research

Central Core Myopathy (Central Core Disease)

10/2019

Structural development of a type-1 ryanodine receptor (RyR1) Ca2+-release channel inhibitor guided by endoplasmic reticulum Ca2+ assay.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroto Iinuma Research Topics

Disease

3	Malignant Hyperthermia 11/2022 - 10/2019
1	Cardiac Arrhythmias (Arrythmia) 12/2023
1	Heat Stroke (Heatstroke) 01/2021
1	Contracture 01/2021
1	Central Core Myopathy (Central Core Disease) 10/2019

Drug/Important Bio-Agent (IBA)

4	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 12/2023 - 10/2019
2	Oxolinic AcidIBA 01/2021 - 10/2019
1	AmidesIBA 12/2023
1	Dantrolene (Dantrium)FDA LinkGeneric 11/2022
1	SaltsIBA 11/2022
1	AcidsIBA 01/2021
1	Caffeine (No Doz)FDA LinkGeneric 01/2021
1	CationsIBA 01/2021
1	Halothane (Fluothane)FDA Link 01/2021
1	Isoflurane FDA LinkGeneric 01/2021
1	CalciumIBA 10/2019

Therapy/Procedure

1	Anesthesia 01/2021